Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06484439 · ClinicalTrials.gov registry record · Early Phase 1
Controlled Trial to Determine Most Effective Post-Operative Analgesia After Third Molar Extraction
A Early Phase 1 study, sponsored by United States Naval Medical Center, San Diego.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 80
- Enrollment target
NCT06484439: Completed Early Phase 1 study, sponsored by United States Naval Medical Center, San Diego.
NCT06484439 is a Early Phase 1 study that has completed, run by United States Naval Medical Center, San Diego. The registered enrollment target is 80 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (51% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06484439, a Early Phase 1 study, has completed, sponsored by United States Naval Medical Center, San Diego.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
This is a prospective randomized clinical trial that will investigate which post-operative medications in conjunction with a multimodal analgesia approach can most effectively control post-operative pain and reduce opioid consumption.
Primary Outcome
All participants will complete a daily survey on the medications taken to relieve pain.
Interventions
- DRUG Acetaminophen
- DRUG Ketorolac
- DRUG Ibuprofen
- DRUG Oxycodone
- DRUG Hydrocodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-02-14 |
| Est. Completion | 2021-12-01 |
| Phase | Early Phase 1 |
What the finished NCT06484439 record still lists
NCT06484439 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (51% higher).
The record links to 0 conditions, and to 5 interventions - of which Acetaminophen is the first listed.
NCT06484439 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06484439 about?
NCT06484439 is a clinical study titled "Controlled Trial to Determine Most Effective Post-Operative Analgesia After Third Molar Extraction". This is a prospective randomized clinical trial that will investigate which post-operative medications in conjunction with a multimodal analgesia approach can most effectively control post-operative pain and reduce opioid consumption.
What is the current status of trial NCT06484439?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 80 participants. The study started on 2018-02-14. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT06484439?
The interventions under investigation include: Acetaminophen (DRUG), Ketorolac (DRUG), Ibuprofen (DRUG), Oxycodone (DRUG), Hydrocodone (DRUG).
Who is sponsoring clinical trial NCT06484439?
This trial is sponsored by United States Naval Medical Center, San Diego, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06484439's enrollment target sits among peer trials
80 271st of 2000 higher than 1,703 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI